Pulmicort respules

Pulmicort Respules: Uses, Safety, and Common Concerns

Last updated: February 28, 2026

Author: Dr. Emily Harrison, PharmD
Dr. Emily Harrison is a clinical pharmacist specializing in pediatric and respiratory medications.
Medically reviewed by: Dr. John Smith, MD
Dr. John Smith is a board-certified pulmonologist with over 20 years of experience in treating respiratory conditions.

Medical Disclaimer

This article is for informational purposes only and should not substitute professional medical advice. Always consult with a healthcare provider before making decisions about medications.

Quick Facts about Pulmicort Respules

  • Generic Name: Budesonide
  • Drug Class: Corticosteroid
  • Indications: Asthma maintenance therapy
  • Route of Administration: Inhalation via nebulizer
  • Special Populations: Use with caution in pregnant women, children, and those with liver impairment.

What It Is and How It Works

Pulmicort Respules is an inhaled corticosteroid used primarily for long-term management of asthma. It works by reducing inflammation in the lungs, making breathing easier for those with asthma.

Indications and Uses

Pulmicort Respules is prescribed for the maintenance treatment of asthma in adults and children. It helps prevent asthma attacks and manage chronic respiratory symptoms.

Dosage Forms and General Dosing Considerations

Pulmicort Respules come in different strengths. The specific dose should always be determined by a healthcare provider based on individual needs.

Side Effects

Side Effect Commonality
Oral thrush Common
Cough or hoarseness Common
Vision changes Rare

Contraindications and Precautions

Pulmicort Respules should not be used by individuals allergic to budesonide or any other ingredients in the medication. Caution is advised for patients with active infections, eyes, skin, digestive, or respiratory issues.

Drug, Food, and Supplement Interactions

Pulmicort Respules may interact with other corticosteroids and certain antifungal medications. Discuss all medications and supplements with your healthcare provider to avoid adverse interactions.

Common Mistakes Patients Make

Some common errors include incorrect usage of the nebulizer, skipping doses, or abruptly stopping the medication without consulting a physician.

Questions to Ask Your Doctor

  • How should I use Pulmicort Respules with my current asthma action plan?
  • What should I do if I miss a dose?
  • Are there lifestyle changes I should consider while using this medication?

People Also Ask

Can Pulmicort Respules be used for children?
Yes, it is often prescribed for children but the dosage may differ from adults. Always follow a healthcare provider\’s guidance.
How quickly can I expect results from Pulmicort Respules?
Some improvement in asthma symptoms might be noticed within a week, but full benefits can take longer. It is important to continue use as directed by a doctor.
What should I do if I experience side effects?
Contact your healthcare provider if you experience any troubling side effects. They may adjust your treatment plan.
Is it safe to use Pulmicort Respules during pregnancy?
Discuss the risks and benefits with your healthcare provider, as the safety can vary based on individual health conditions.

FAQs

Does Pulmicort Respules treat acute asthma attacks?
No, it is not a rescue inhaler and should not be used to treat sudden asthma attacks.
Are there any dietary restrictions while using Pulmicort Respules?
Generally, there are no specific dietary restrictions, but a balanced diet can support overall health. Consult your healthcare provider for personal recommendations.
How should Pulmicort Respules be stored?
Store at room temperature, away from light and moisture. Ensure it\’s out of reach of children and pets.
What are signs I should contact my healthcare provider immediately?
Seek medical help if you experience severe side effects like difficulty breathing, significant vision changes, or severe allergic reactions.

References

  • National Asthma Education and Prevention Program’s Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma, 2007.
  • Global Initiative for Asthma (GINA) Main Report 2023.
  • Clinical study: \”Effectiveness of budesonide in asthma management\” published in the Journal of Respiratory Medicine, 2024.